HDAC6 Degradation Inhibits the Growth of High-Grade Serous Ovarian Cancer Cells
Histone deacetylase 6 (HDAC6) is a unique histone deacetylating enzyme that resides in the cell cytoplasm and is linked to the modulation of several key cancer related responses, including cell proliferation and migration. The promising anti-cancer response of the first-generation HDAC6 catalytic in...
Main Authors: | Ahlam Ali, Fengyu Zhang, Aaron Maguire, Tara Byrne, Karolina Weiner-Gorzel, Stephen Bridgett, Sharon O’Toole, John O’Leary, Caitlin Beggan, Patricia Fitzpatrick, Amanda McCann, Fiona Furlong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/12/3734 |
Similar Items
-
HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
by: Andressa S. Laino, et al.
Published: (2019-02-01) -
Ricolinostat (ACY-1215) inhibits VEGF expression via PI3K/AKT pathway and promotes apoptosis in osteoarthritic osteoblasts
by: Lei Li, et al.
Published: (2019-10-01) -
ACY-1215 exhibits anti-inflammatory and chondroprotective effects in human osteoarthritis chondrocytes via inhibition of STAT3 and NF-κB signaling pathways
by: Chao Cheng, et al.
Published: (2019-01-01) -
Inhibition of HDAC6 attenuates LPS-induced inflammation in macrophages by regulating oxidative stress and suppressing the TLR4-MAPK/NF-κB pathways
by: Wen-bin Zhang, et al.
Published: (2019-09-01) -
Quantitative Proteomic Analysis Reveals the Sites Related to Acetylation and Mechanism of ACY-1215 in Acute Liver Failure Mice
by: Wen-bin Zhang, et al.
Published: (2019-06-01)